I read a recent article [1.] about the state of the antibiotics companies. It was interesting and revealed how over-prescription, fear of over-prescription, and market economics have governed the fate of promising new drugs.

[1.] https://www.nytimes.com/2019/12/25/health/antibiotics-new-re...

I like the idea of bacteriophage therapy and would like to see this field researched more in the U.S. Here is an article about the limits on wider use of bacteriophage therapy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821673/